Closed

Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional

Food and Drug Administration·Government

AI Summary

The Food and Drug Administration seeks to support the use of digital health technologies in clinical investigations for drug and biological product development. This funding opportunity is for clinical trials that utilize digital health technologies to improve clinical trial design, conduct, and outcomes. The goal is to advance the development of digital health technologies for use in clinical trials.

Deadline
Thursday, August 20, 2026
Value
Not specified
Location
US
Contract
Not specified
Duration
Not specified
Remote
Not specified
Source
grants-gov
Posted
July 20, 2026
Team Size
Not specified

Tech Stack

digital health technologies

Full Description

Title: Use of Digital Health Technologies in Clinical Investigations to Support Drug and Biological Product Development (U01) Clinical Trials Optional Agency: Food and Drug Administration Agency Code: HHS-FDA Status: posted Document Type: synopsis Open Date: 07/20/2026 Close Date: 08/20/2026 CFDA Numbers: 93.103 Opportunity Number: RFA-FD-26-012 Opportunity ID: 363255
View Original RFP